HomeABCL • NASDAQ
add
AbCellera Biologics Inc
$3.56
Makalipas ang Oras ng Trabaho:(0.98%)+0.035
$3.60
Sarado: Dis 5, 6:47:43 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$3.65
Sakop ng araw
$3.53 - $3.69
Sakop ng taon
$1.89 - $6.52
Market cap
1.07B USD
Average na Volume
4.71M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 8.96M | 37.62% |
Gastos sa pagpapatakbo | 30.20M | -48.98% |
Net na kita | -57.12M | -11.76% |
Net profit margin | -637.84 | 18.79% |
Kita sa bawat share | -0.19 | -11.76% |
EBITDA | -71.03M | -25.18% |
Aktuwal na % ng binabayarang buwis | 16.94% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 495.67M | -22.93% |
Kabuuang asset | 1.36B | -2.64% |
Kabuuang sagutin | 391.95M | 24.54% |
Kabuuang equity | 964.04M | — |
Natitirang share | 299.34M | — |
Presyo para makapag-book | 1.13 | — |
Return on assets | -13.83% | — |
Return on capital | -16.91% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -57.12M | -11.76% |
Cash mula sa mga operasyon | -52.59M | -82.10% |
Cash mula sa pag-invest | 36.49M | 886.70% |
Cash mula sa financing | 7.37M | 134.40% |
Net change in cash | -9.28M | 57.19% |
Malayang cash flow | -44.36M | -323.45% |
Tungkol
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Itinatag
2012
Headquarters
Website
Mga Empleyado
596
